The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwCLL 2017 | The circle of CLL
Carlo Croce, MD from Ohio State University, Columbus, OH provides an interesting overview of chronic lymphocytic leukemia (CLL) at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 held in New York, NY. Prof. Croce provides an insight into the discovery of the genetic mechanism and targets of CLL. He explains in detail the advances in CLL in terms of drug therapies which have been able to target the BCL2 gene, a gene he discovered, which has revolutionized treatment for CLL patients.
